Optical spectroscopy: current advances and future applications in cancer diagnostics and therapy
- 1 March 2012
- journal article
- review article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 8 (3), 307-320
- https://doi.org/10.2217/fon.12.15
Abstract
Optical spectroscopy (OS) is a tissue-sensing technique that could enhance cancer diagnosis and treatment in the near future. With OS, tissue is illuminated with a selected light spectrum. Different tissue types can be distinguished from each other based on specific changes in the reflected light spectrum that are a result of differences on a molecular level between compared tissues. Therefore, OS has the potential to become an important optical tool for cancer diagnosis and treatment monitoring. In recent years, significant progress has been made in the discriminating abilities of OS techniques between normal and cancer tissues of multiple human tissue types. This article provides an overview of the advances made with diffuse reflectance, fluorescence and Raman spectroscopy techniques in the field of clinical oncology, and focuses on the different clinical applications that OS could enhance.Keywords
This publication has 86 references indexed in Scilit:
- Use of new imaging techniques to predict tumour response to therapyThe Lancet Oncology, 2010
- Functional Imaging of Colorectal Cancer: Positron Emission Tomography, Magnetic Resonance Imaging, and Computed TomographyClinical Colorectal Cancer, 2009
- Advances in quantitative UV–visible spectroscopy for clinical and pre-clinical application in cancerCurrent Opinion in Biotechnology, 2009
- Quantitative diffuse reflectance and fluorescence spectroscopy: tool to monitor tumor physiology in vivoJournal of Biomedical Optics, 2009
- New Technologies for Human Cancer ImagingJournal of Clinical Oncology, 2008
- Recent applications of near-infrared spectroscopy in cancer diagnosis and therapyAnalytical and Bioanalytical Chemistry, 2007
- Monitoring Breast Cancer Response to Neoadjuvant Systemic Chemotherapy Using Parametric Contrast-Enhanced MRI: A Pilot StudyAcademic Radiology, 2007
- Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopyProceedings of the National Academy of Sciences of the United States of America, 2007
- Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapyJournal of Biomedical Optics, 2007
- High frame‐rate simultaneous bilateral breast DCE‐MRIMagnetic Resonance in Medicine, 2006